Malcolm R, Ballenger J C, Sturgis E T, Anton R
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425-0742.
Am J Psychiatry. 1989 May;146(5):617-21. doi: 10.1176/ajp.146.5.617.
Of 86 alcoholic men with severe alcohol withdrawal who began a double-blind controlled study comparing carbamazepine, 800 mg/day, to oxazepam, 120 mg/day, 66 (carbamazepine, N = 32; oxazepam, N = 34) completed the 7-day trial. In general, the drugs were found to be equally efficacious in treating the withdrawal syndrome and not significantly different with respect to side effects. The subjects taking oxazepam had an increase in global psychological distress from day 3 to day 7, and those taking carbamazepine exhibited a decline. The study suggests that carbamazepine is as effective and safe as benzodiazepine treatment for alcohol withdrawal.
86名患有严重酒精戒断症状的男性开始了一项双盲对照研究,比较每天800毫克卡马西平与每天120毫克奥沙西泮的疗效。其中66人(卡马西平组32人,奥沙西泮组34人)完成了为期7天的试验。总体而言,发现这两种药物在治疗戒断综合征方面同样有效,且副作用无显著差异。服用奥沙西泮的受试者从第3天到第7天整体心理困扰有所增加,而服用卡马西平的受试者则有所下降。该研究表明,卡马西平在治疗酒精戒断方面与苯二氮䓬类药物同样有效且安全。